Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Impileo Lifescience is an Indian pharmaceutical company headquartered in Panchkula, Haryana, specializing in the manufacturing and marketing of a broad spectrum of healthcare products. The company operates primarily through a PCD (Propaganda Cum Distribution) Pharma Franchise model, offering a wide range of DCGI-approved formulations including tablets, capsules, injectables, and syrups. Their therapeutic focus spans across several key areas such as cardiology, gynecology, orthopedics, and gastroenterology. Impileo Lifescience emphasizes quality assurance, utilizing GMP-certified manufacturing facilities to provide affordable generic medicines. The company also provides third-party manufacturing services to other pharmaceutical entities, leveraging its robust supply chain and production capabilities. It is an ISO 9001:2015 certified organization committed to expanding its reach within the Indian domestic market through strategic franchise partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Impileo Lifescience.